Evaluation of the effect of squill oxymel In COPD
Not Applicable
- Conditions
- chronic obstructive pulmonary disease (COPD).Chronic obstructive pulmonary disease, unspecified
- Registration Number
- IRCT2016040919912N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Age 18 to 60 years; patients with GOLD stage IIA COPD who have clinical criteria include: FEV1/FVC less than 0.7 of the predicted and FEV1 between 50% to 80% of the predicted; treated with conventional drugs; Lack of pregnancy; Lack of breastfeeding; Lack of the use other herbal medicines; Lack of active peptic ulcer and cardiovascular disease (especially heart block) or renal disease; Not concomitant use of anticoagulant; Non-smoking. Exclusion criteria: Add or remove the drugs that interferes with COPD (such as NSAIDs); Infections leading to hospitalization; the patient's unwillingness to continue treatment.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Distance traveled in the 6MWT. Timepoint: Before and after the intervention (end of week 6). Method of measurement: 6-minute walk test (6MWT).
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: before and after the intervention (6 week). Method of measurement: quality of life questionnaires St. George (SGRQ).;Blood oxygen saturation (SaO2). Timepoint: before and after the intervention (6 week). Method of measurement: 6-minute walk test (6MWT).